• Mashup Score: 8

    Explore clinical research, expert reviews, and comment and opinion from The Lancet Rheumatology. A voice for rheumatology specialists worldwide

    Tweet Tweets with this article
    • Our Sept issue is live! Including a #GBDstudy on #osteoarthritis, a trial in acute calcium pyrophosphate crystal #arthritis, a global comment on #hydroxychloroquine use during #pregnancy, plus much more! https://t.co/XGoKvOAJDo Cover by Grace Russell (@Gracie_25) https://t.co/6Y5yG6mhpu

  • Mashup Score: 0

    DESTIN, Fla. — Low disease activity and remission are achievable for patients with lupus if clinicians “minimize the prednisone” and administer adequate hydroxychloroquine, noted a speaker at the 2023 Congress of Clinical Rheumatology-East.

    Tweet Tweets with this article
    • “We are not using enough #HydroxyChloroquine [for #lupus],” Dr. Michelle Petri @jhrheumatology told #CCREast attendees. “Don’t be afraid to use our medications; if you don’t use it in a real dose, the patient cannot benefit from it.” #RheumTwiter https://t.co/LS1tqTCvbt https://t.co/tFSBlnzUkp

  • Mashup Score: 0

    Can’t sign in? Forgot your password? Enter your email address below and we will send you the reset instructions If the address matches an existing account you will receive an email with instructions to reset your password. Request Username Can’t sign…

    Tweet Tweets with this article
    • The latest from Annals of Internal Medicine is online now. Explore new research on #hydroxychloroquine, Epstein-Barr virus, and more: https://t.co/WaNYrPcPg1 https://t.co/Quh9mX7P7W